Search
for
Sort by
Research 61–90 of 1000+
- Author response: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- A new self‐reported measure of disease severity of scalp hair loss in alopecia areata
- Androgens’ Effects across the Lifespan in Men and Animal Models
- Decision letter: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- A comment on the post-finasteride syndrome
- PolyQ length co-evolution in neural proteins
- A Review on the Form and Complexity of Human–Robot Interaction in the Evolution of Autonomous Surgery
- Expert Opinion: Migraine, Psychiatric Comorbidities, and Treatment
- Incel Identity Development: A Scoping Review of Biopsychosocial Markers
- Hair Loss, Body Height and Attractiveness Malus for Men
- Prioritizing susceptibility genes for the prognosis of male-pattern baldness with transcriptome-wide association study
- Notes from the Editor Emeritus: Coincidental Epigenetics or Post-Finasteride Syndrome (PFS)?
- Role of Phenylalanine and Its Metabolites in Health and Neurological Disorders
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Transcranial photobiomodulation for brain diseases: review of animal and human studies including mechanisms and emerging trends
- Twenty-Five and Up (25Up) Study: A New Wave of the Brisbane Longitudinal Twin Study
- Hair Follicles as a Critical Model for Monitoring the Circadian Clock
- Innovative Reports on the Effects of Anabolic Androgenic Steroid Abuse—How to Lose Your Mind for the Love of Sport
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Synthesis and Actions of 5α-Reduced Metabolites of Testosterone in the Nervous System
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Genetic prediction of male pattern baldness
- Skin aging: mechanisms, evaluation, and rejuvenation